Singapore markets close in 1 hour 29 minutes
Straits Times Index
3,289.94 -2.75 (-0.08%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,199.02 +435.99 (+2.46%) FTSE 100
8,141.39 +20.15 (+0.25%) Bitcoin USD
57,712.88 -226.79 (-0.39%) CMC Crypto 200
1,265.37 -5.37 (-0.42%)
TScan Therapeutics, Inc. (TCRX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 7.72 |
| Open | 7.75 |
| Bid | 8.55 x 100 |
| Ask | 8.67 x 100 |
| Day's range | 7.75 - 8.70 |
| 52-week range | 1.93 - 9.00 |
| Volume | |
| Avg. volume | 210,698 |
| Market cap | 455.677M |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
TScan Therapeutics (TCRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Hedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16%
Key Insights Significantly high institutional ownership implies TScan Therapeutics' stock price is sensitive to their...
- GuruFocus.com
TScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands Clinical Pipeline
Fourth Quarter and Full Year 2023 Financial Results and Business Developments
© 2024 Yahoo. All rights reserved.